Daily Report | Global Markets Closed Mixed

The momentum for JCI to rally was seen to continue, accompanied by foreign net buying, particularly in telecommunications stocks. In the short term, as long as the JCI is able to maintain above 5,600, there will be an opportunity to go to the next target at 5,860.

Last SUN Auction 2020

The benchmark SUN price slightly strengthened, amid various responses related to the Biden transition period and the cabinet announcement.

Daily Report | JCI Daily Transaction at Record High

From the domestic market, investors are seen starting to take profit taking after the relatively high JCI hike. Yesterday’s trading was marked by a record high daily transaction value of IDR18.6 trillion. For today, JCI is likely to continue declining with a range of 5,650-5,685.

Daily Report | Dow Jones Breaks Through 30,000

The good news from the US has energized almost all stock exchanges in the world, including the JCI, which managed to break the 5,700 level. However, the rally of the JCI yesterday was also accompanied by the formation of a gap in the 5652-5677 area. Meanwhile, foreign net buy is also seen in a downward trend compared to the beginning of November.

Daily Report | Waiting for Breakout Confirmation

The sharp increase in the JCI yesterday succeeded in bringing the benchmark index to its highest position since the market crash in March 2020. Technically, after successfully breaking a fairly strong resistance level, JCI will try to hold above 5,600 to confirm a strengthening trend.

BI 7-DRRR and NPI Support Weekend Market

Last Thursday, the results of the Bank Indonesia (BI) Board of Governors (RDG) Meeting for the November 2020 period decided to lower the BI 7 Day Reverse Repo Rate (BI 7-DRRR) by 25 bps to 3.75%.

Weekly Report | Prospect of Property Sector

JCI’s movement was influenced by domestic sentiments from the release of trade balance and balance of payment data, to BI’s decision to cut BI-7DRRR. Meanwhile, global markets were influenced by the development of covid-19 vaccine by Moderna.